SCHEMBL3923979

SCHEMBL3923979

COc1ccc(CNc2cc(CC=O)ccn2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 7/20 0.53
DYRK1A Q13627 4/20 0.50
NR3C2 P08235 1/20 0.50
CLK1 P49759 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KMT2A Q03164 2/20 0.47
IGF1R P08069 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ASPH Q12797 1/20 0.46
KDM8 Q8N371 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK10 P53779 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28131061 0.85 CLK4 (0.57) CLK4DYRK1ANR3C2CLK1NPC1
SCHEMBL3159168 0.83 CLK4 (0.56) CLK4DYRK1ANR3C2CLK1NPC1
SCHEMBL17393176 0.82 CLK4 (0.54) CLK4DYRK1ANR3C2CLK1NPC1
SCHEMBL8422251 0.80 MEN1 (0.68) CLK4DYRK1ACLK1NPC1RAB9A
SCHEMBL436482 0.77 CLK4 (0.55) CLK4DYRK1ANR3C2CLK1KDM4E
SCHEMBL439371 0.77 CLK4 (0.66) CLK4DYRK1ACLK1NPC1RAB9A
SCHEMBL8224486 0.77 CLK4 (0.54) CLK4DYRK1ACLK1NPC1RAB9A
SCHEMBL346269 0.76 KMT2A (0.67) CLK4DYRK1ACLK1NPC1RAB9A
SCHEMBL27766207 0.75 CLK4 (0.53) CLK4DYRK1ANR3C2CLK1KMT2A
SCHEMBL20840603 0.75 NPC1 (0.51) CLK4DYRK1ANPC1IGF1RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032562-A2 SELECTIVE INHIBITORS OF ROCK PROTEIN KINASE AND USES THEREOF Vertex Pharmaceuticals Incorporated (US) 2009-03-11 EP disclosed
WO-2007133622-A2 SELECTIVE INHIBITORS OF ROCK PROTEIN KINASE AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-11-22 WO disclosed